FindTrial
Sign In

REX-001

DRUG2 trials

Sponsors

Ixaka Ltd

Conditions

Cardiovascular DiseaseCritical Limb Ischemia (CLI)Diabetes Mellitus (DM)Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Peripheral Arterial Disease (PAD)

Phase 3

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
TerminatedNCT03111238
Ixaka LtdCardiovascular Disease, Critical Limb Ischemia (CLI), Diabetes Mellitus (DM) +3
Start: 2017-04-05End: 2021-03-31Updated: 2021-05-07
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
TerminatedNCT03174522
Ixaka LtdCardiovascular Disease, Critical Limb Ischemia (CLI), Diabetes Mellitus (DM) +3
Start: 2017-04-25End: 2023-02-13Updated: 2023-03-16